DanCann Pharma A/S Logo

DanCann Pharma A/S

DANCAN | SPGR

Overview

Corporate Details

ISIN(s):
DK0061410487
LEI:
549300KLXQ6IC2YUUB58
Country:
Denmark
Address:
Rugvænget 5, 6823 Ansager
Sector:
Health Care
Industry:
Pharmaceuticals

Description

DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AstraZeneca PLC Logo AstraZeneca PLC United Kingdom AZN
Basilea Pharmaceutica AG Logo Basilea Pharmaceutica AG Switzerland BSLN
Bayer AG Logo Bayer AG Germany BAY
Biogened Spolka Akcyjna Logo Biogened Spolka Akcyjna Poland BGD
Biotika A.S. Logo Biotika A.S. Slovakia BSL
Bio Vitos Pharma AB Logo Bio Vitos Pharma AB Sweden BIOVIT
BOIRON Logo BOIRON France BOI
Bonyf N.V. Logo Bonyf N.V. Belgium MLBON
Bosnalijek d.d. Sarajevo Logo Bosnalijek d.d. Sarajevo Bosnia and Herzegovina BSNL
Calliditas Therapeutics Logo Calliditas Therapeutics Sweden CALTX